Testing effectiveness (Phase 2)Study completedNCT00006475What this trial is testingSTI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast CrisisWho this might be right forLeukemia Novartis
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982What this trial is testingCombination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more M.D. Anderson Cancer Center 88
Testing effectiveness (Phase 2)Ended earlyNCT00006220What this trial is testingArsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Washington University School of Medicine 5
Testing effectiveness (Phase 2)Study completedNCT00003960What this trial is testingDonor Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Large-scale testing (Phase 3)Ended earlyNCT00089141What this trial is testingMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)Who this might be right forCancer Martin, Paul 151
Testing effectiveness (Phase 2)Looking for participantsNCT06892223What this trial is testingAnti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical TransplantationWho this might be right forAcute Myeloid LeukaemiaMDS (Myelodysplastic Syndrome)MPN (Myeloproliferative Neoplasms) Istituto Clinico Humanitas 42
Testing effectiveness (Phase 2)Study completedNCT00002673What this trial is testingImmunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Early research (Phase 1)Study completedNCT00005092What this trial is testingChemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT03387475What this trial is testingEvaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA AgentsWho this might be right forMyelodysplasia University Hospital, Grenoble 39
Early research (Phase 1)Study completedNCT03358719What this trial is testingDEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaBlasts 30 Percent or Less of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia+3 more Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT00462605What this trial is testingMS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004061What this trial is testingBiological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerWho this might be right forLeukemiaLymphomaOral Complications Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)WithdrawnNCT05612633What this trial is testingZelavespib (PU-H71) in Subjects With AP-MPN or BP-MPNWho this might be right forAccelerated Phase MPNBlast Phase MPN Samus Therapeutics, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT01670084What this trial is testingNilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more Mayo Clinic
Early research (Phase 1)Looking for participantsNCT03595917What this trial is testingABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CMLWho this might be right forB-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL Marlise Luskin, MD 40
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40